Thermo Scientific Vios iDx CO2 Incubator (CBOT)

The Food and Drug Administration is forecasting the procurement of a Thermo Scientific Vios iDx CO2 Incubator to replace an outdated unit in its Select Agent Laboratory, ensuring continued compliance with biosafety and operational standards. The acquisition is classified under NAICS code 541990, indicating it falls under scientific research and development services, and is intended to maintain the integrity of sensitive biological research conducted within the facility. The contract action is currently in the pre-solicitation phase, with no solicitation number assigned and no set-aside designation specified, suggesting it may be open to all eligible vendors. The point of contact for program inquiries is the Hfp Acquisition Liaison, reachable via hfpacquisitions@fda.hhs.gov, while the contracting officer position is marked as to be determined. The place of performance and organizational address details have not been finalized, indicating that the specific lab location within the FDA’s infrastructure has not been disclosed publicly. This forecast provides vendors with early visibility into the upcoming requirement, allowing them to prepare proposals and ensure their equipment meets the stringent needs of a Select Agent Laboratory environment. The posting date of May 25, 2026, signals the forecast timeline, though actual procurement activity is expected to follow in subsequent months.